Evidence map›Paper›PMID 35301252›Full record

ReviewOpen heart2022

Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity.

James J DiNicolantonio, Mark F McCarty, Simon Iloki Assanga, Lidianys Lewis Lujan, James H O'Keefe

Open access · goldAbstract readReview
In one paragraph

Review in Open heart, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Mitochondrial Resilience in Glaucoma: Targeting NADDiseases (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Hyperlipidaemia treatment and gut microbiology.Frontiers in microbiology · 2024
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

James J DiNicolantonioPreventive Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA jjdinicol@gmail.com.ORCID 0000-0002-7888-1528
Mark F McCartyCatalytic Longevity Foundation, St Helier, Jersey.
Simon Iloki AssangaDepartment of Research and Postgraduate in Food Science, University of Sonora, Hermosillo, Mexico.
Lidianys Lewis LujanDepartment of Research and Postgraduate in Food Science, University of Sonora, Hermosillo, Mexico.
James H O'KeefeCharles and Barbara Duboc Cardio Health & Wellness Center, St Luke's Mid America Heart Institute, Kansas City, Missouri, USA.ORCID 0000-0002-3376-5822
Universidad de Sonora · MXCatalytic Longevity · USSaint Luke's Health System · USSaint Luke's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferulic acid, a bacterial metabolite of anthocyanins, seems likely to be a primary mediator of the health benefits associated with anthocyanin-rich diets, and has long been employed in Chinese cardiovascular medicine. In rodent studies, it has exerted wide-ranging antioxidant and anti-inflammatory effects, the molecular basis of which remains rather obscure. However, recent studies indicate that physiologically relevant concentrations of ferulic acid can boost expression of Sirt1 at mRNA and protein levels in a range of tissues. Sirt1, a class III deacetylase, functions to detect a paucity of oxidisable substrate, and in response works in various ways to promote cellular survival and healthful longevity. Sirt1 promotes 'cell cleansing' and cell survival by boosting autophagy, mitophagy, mitochondrial biogenesis, phase 2 induction of antioxidant enzymes via Nrf2, and DNA repair-while inhibiting NF-kB-driven inflammation, apoptosis, and cellular senescence, and boosting endothelial expression of the protective transcription factor kruppel-like factor 2. A deficit of the latter appears to mediate the endothelial toxicity of the SARS-CoV-2 spike protein. Ferulic acid also enhances the activation of AMP-activated kinase (AMPK) by increasing expression and activity of its activating kinase LKB1-whereas AMPK in turn amplifies Sirt1 activity by promoting induction of nicotinamide phosphoribosyltranferase, rate-limiting for generation of Sirt1's obligate substrate NAD+. Curiously, AMPK acts by independent mechanisms to potentiate many of the effects mediated by Sirt1. Hence, it is proposed that ferulic acid may exert complementary or synergistic health-promoting effects when used in conjunction with clinically useful AMPK activators, such as the nutraceutical berberine. Additional nutraceuticals which might have potential for amplifying certain protective effects of ferulic acid/berberine are also discussed.

Indexed as

BerberineCOVID-19AMP-Activated Protein KinasesAnthocyaninsCoumaric AcidsHumansLongevitySARS-CoV-2Sirtuin 1Spike Glycoprotein, CoronavirusAMP-Activated Protein KinasesAnthocyaninsBerberineCoumaric Acidsferulic acidSIRT1 protein, humanSirtuin 1Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2carotid artery diseasescoronary angiographyechocardiography

Identifiers

PMID35301252
PMCPMC8932268
OpenAlexW4221082587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.